Long-term safety and effectiveness of canakinumab in CAPS: results from the β-Confident Registry
Kuemmerle-Deschner JB, Ramos E, Engel K, et al.
RMD Open · 2021
Key Findings
- ●Real-world registry
- ●6-year safety and effectiveness data
Referenced in (1 disease)
Validation history
Full log →No validation events recorded yet. Source will be checked on the next kipine-source-validator run.
ID: pmid-34001647PMID: 34001647